News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Thor Halfdanarson Reflects on New Study About Impact of Therapy on Quality of Life in Patients With NETs
Thor Halfdanarson/mayoclinic.org
Sep 3, 2025, 08:23

Thor Halfdanarson Reflects on New Study About Impact of Therapy on Quality of Life in Patients With NETs

Thor Halfdanarson, Professor of Oncology at Mayo Clinic School of Medicine, shared on X:

“Impact of therapy on quality of life in patients with NETs. Not surprisingly, SSAs and PRRT/RLT has a positive impact, especially among those with a functional syndrome. Targeted therapy (MKIs/mTORi) less so which is not surprising.

Depression common…”

Title: Impact of treatment on quality of life in neuroendocrine neoplasm survivors

Authors: Roberta Modica, Elio Benevento, Anna La Salvia, Rossella Mazzilli, Carla Pandozzi, Giulia Pecora, Luigi Barrea, Annamaria Colao, Antongiulio Faggiano

Read The Full Article at Endocrine-Related Cancer.

Thor Halfdanarson Reflects on New Study About Impact of Therapy on Quality of Life in Patients With NETs

More posts featuring Thorvardur Halfdanarson.

Anna La Salvia Annamaria Colao Antongiulio Faggiano cancer Carla Pandozzi Elio Benevento Giulia Pecora Luigi Barrea OncoDaily Oncology Roberta Modica Rossella Mazzilli Thor Halfdanarson
Special Coverage
Science
Sep 3, 2025, 08:23
Thor Halfdanarson Reflects on New Study About Impact of Therapy on Quality of Life in Patients With NETs
Science
Sep 3, 2025, 08:11
Sanam Loghavi: Cytomolecular Drivers of Relapse After Frontline FLT3 Inhibitor Therapy in FLT3-Mutated AML
Voices
Sep 3, 2025, 08:06
Douglas Flora: What it's Like to Be a Cancer Patient - Leaves, Branches, and Roots
Voices
Sep 3, 2025, 08:01
No Child Left Behind: Prioritizing Childhood Cancer in the Next EU Budget - AIEOP
Voices
Sep 3, 2025, 07:58
Anh Lam: Join us in Chicago for ASCO Quality Care Symposium
Insight
Sep 3, 2025, 07:55
Oncology Updates: August Edition from BG Lab
Science
Sep 3, 2025, 07:49
Alessandro Di Federico: Not All Oncogenes Are the Same
Career Updates
Sep 3, 2025, 07:48
Matthew Kurian: Registration is Open for Implications of HER2 Testing in Cancer Management Session
Voices
Sep 3, 2025, 07:37
Tyler Seibert: Rare but Tragic Outcomes After Radiation for Pelvic Cancers
Societies
Sep 3, 2025, 07:28
Free Childcare for Congress Delegates With Children Aged 1–12 - ESGO
Voices
Sep 3, 2025, 07:14
Eric Whitman: Register for Virtual Post-ASCO Conference on September 20
Science
Sep 3, 2025, 07:05
Jean-Jacques Kiladjian: Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement